Recruitment open for an investigational medication trial for treatment of Major Depressive Disorder (MDD)
Study Details
Researchers at the Oregon Research Institute (ORI) are recruiting for a study funded by Vanda Pharmaceuticals Inc. that evaluates whether a new investigational medication (milsaperidone) safely and effectively improves depressive symptoms when taken alongside current medication.
The study is looking for people who are:
- 18 to 65 years old
- Diagnosed with major depressive disorder
- Currently experiencing a serious depressive episode
- Currently taking an antidepressant medication with partial response
What participants can expect:
- If eligible, participants will be randomly assigned to either receive the study medication or a placebo for 6 weeks.
- After 6 weeks, all study participants can optionally continue taking the study medication for one year.
- Routine mental and physical health checks, including blood draws, will be performed.
- There will be up to 19 visits (depending on whether participants enroll in the optional year) each lasting between 4-6 hours.
- Participants will receive a stipend at each visit for time and travel.
Other ways to contact us:
(541) 434-1527 (call or text)
Complete our interest form to be considered for this study or any other clinical research opportunities:
